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Abstract
Ecto-phosphorylation plays an important role in many cellular functions. The transmembrane glycoprotein CD98 contains
potential phosphorylation sites in its extracellular C-terminal tail. We hypothesized that extracellular signaling through ecto-
protein kinases (ePKs) might lead to ecto-phosphorylation of CD98 and influence its multiple functions, including its role in
cell-cell interactions. Our results show that recombinant CD98 was phosphorylated in vitro by ePKs from Jurkat cells and by
the commercial casein kinase 2 (CK2). Alanine substitutions at serines-305/307/309 or serines-426/430 attenuated CK2-
mediated CD98 phosphorylation, suggesting that these residues are the dominant phosphorylation sites for CK2.
Furthermore, CD98 expressed in the basolateral membranes of intestinal epithelial Caco2-BBE cells was ecto-
phosphorylated by Jurkat cell-derived ePKs and ecto-CK2 was involved in this process. Importantly, cell attachment
studies showed that the ecto-phosphorylation of CD98 enhanced heterotypic cell-cell interactions and that the extracellular
domain of CD98, which possesses the serine phosphorylation sites, was crucial for this effect. In addition, phosphorylation of
recombinant CD98 increased its interactions with Jurkat and Caco2-BBE cells, and promoted cell attachment and spreading.
In conclusion, here we demonstrated the ecto-phosphorylation of CD98 by ePKs and its functional importance in cell-cell
interactions. Our findings reveal a novel mechanism involved in regulating the multiple functions of CD98 and raise CD98 as
a promising target for therapeutic modulations of cell-cell interactions.
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Introduction
CD98, a type II transmembrane glycoprotein, is a potential
regulator of multiple functions, including extracellular signaling,
epithelial cell adhesion/polarity, amino-acid transport and cell-cell
interactions [1]. Following its discovery as a surface antigen in
lymphocytes [2], CD98 has been found to be expressed in all cell
types with the exception of platelets, and is expressed at highest
levels in the gastrointestinal tract and the tubules of the kidney [1].
In intestinal epithelial cells (IECs), CD98 is targeted to the
basolateral membranes and forms heterodimers with amino-acid
transporters. These CD98/amino-acid transporter heterodimers
have been shown to associate with b1-integrin and function as a
b1-integrin regulator [3,4,5,6].
Extracellular (Ecto-) phosphorylation is emerging as an
important mechanism in the regulation of many physiological
processes, such as cell-cell interactions, cellular differentiation and
proliferation, ion fluxes and cellular activation [7]. A variety of
cells, such as immune cells, have been reported to possess ecto-
protein kinases (ePKs) [7]. ePKs have been identified as plasma
membrane-associated protein kinases that act on the outer surface
of cells [8]. ePKs, which can be released from intact cells in a
process termed ‘‘shedding’’ [9], are capable of phosphorylating
cell-surface proteins, extracellular matrix proteins and soluble
substrates using extracellular ATP as a phosphate donor. Casein
kinase 2 (CK2) is a highly conserved ePK expressed in nearly every
eukaryotic tissue and cellular compartment [10,11], and can
phosphorylate numerous proteins [12,13]. Although CK2 does
exhibit some tyrosine kinase activity, it mainly phosphorylates
serine or threonine residues [10].
Inspection of the human CD98 primary sequence revealed the
presence of potential phosphorylation sites in its C-terminal
extracellular domain. We therefore hypothesized that extracellular
signaling through ePKs might lead to ecto-phosphorylation of
CD98 and influence its multiple functions. Since cell-cell
interactions are of great importance in the functioning of the
immune system, we searched for a phosphorylation of CD98 by
ePKs from T lymphocytes and further examined whether the ecto-
phosphorylation of CD98 could modulate heterotypic interactions
between IECs and T lymphocytes.
Materials and Methods
Cell culture
The human intestinal epithelial Caco2-BBE cell line and CHO
cells were grown in DMEM (Invitrogen, Carlsbad, CA) supple-
mented with 10% FBS (Invitrogen) and 1.5 mg/ml plasmocin
(Invivogen). The human T-lymphoblastoid Jurkat E6-1 cell line
was cultured in RPMI 1640 (Invitrogen) supplemented with 10%
FBS and 1.5 mg/ml plasmocin.
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The CD98/pTarget plasmid, constructed as previously described
[5], was used as a template to generate CD98 construct variants.
Full-length CD69 was cloned from macrophage KG1 cell line.
CD69-CD98 chimeras were constructed by PCR-mediated overlap
extension. CD69 truncated mutant lacking the extracellular domain
(amino acid 62–199*) was generated using specific primers p3-ATG
AGC TCT GAA AAT TGT TTC GTA GC and p4-GAA GAG
CAG CAG CAG TGC CCA TTG GAA GGA CCC TTC ATC.
CD98 truncated mutant lacking the cytoplasmic and transmem-
brane domains (amino acids 1–104*) was generated using specific
primers p1-CAT GAA GGG TCC TTC CAA TGG GCA CTG
CTGCTGCTCTTCand p2-GGCCGCGTA GGGGAAGCG
GAG CAG CAG. PCR products were added together to a further
PCR using Platinum DNA polymerase (Invitrogen) and specific
primers p3 and p2 to obtain C69-T69-E98 sequence. Wild-type
CD98 and the chimeras were subcloned into the pcDNA3.1/V5-
His-TOPO vector (Invitrogen). *Numbering was based on the
amino acid sequence reported for human CD69 (entry Q07108)
and human CD98 (4F2; entry P08195) of the Swiss-Prot database.
The CD98-pcDNA3.1/V5-His-TOPO S305A-S307A-S309A
mutant was generated by changing the codon at 1440–1442*,
1446–1448* and 1452–1454* position from serine 305, 307 and
309, respectively, to alanines using specific primers P1 (forward,
59-C TCA TAC CTG GCT GAT GCT GGC GCC ACT GGG
GAG C-39; reverse, 59-G CTC CCC AGT GGC GCC AGC
ATC AGC CAG GTA TGA G-39). The CD98-pcDNA3.1/V5-
His-TOPO S426A-S430A mutant was generated by changing the
codon at 1803–1805* and 1815–1817* position from serine 426
and 430, respectively, to alanines using specific primers P2
(forward, 59-TTC CGG CGG CTA GCT GAC CAG CGG GCT
AAG GAG CGC-39; reverse, 59-GCG CTC CTT AGC CCG
CTG GTC AGC TAG CCG CCG GAA-39). Site-directed
mutagenesis by PCR-mediated overlap extension was performed
using QuikChange
TM Site-Directed Mutagenesis Kit (Stratagene,
La Jolla, CA). *Based on NCBI NM002394 numbering; 1
st
methionine (start of translation)=225.
CHO cells were transfected with the constructs using Lipofectin
(Invitrogen) and stably selected in culture media supplemented
with 1.2 mg/ml geneticin (Invitrogen).
Generation of TetR Caco2-BBE cell line containing CD98-
shRNA constructs
Caco2-BBE cells were first transfected with the pcDNA4/TO/
myc-His/lacZ vector (Invitrogen), which encodes the tetracycline
repressor (TetR). This TetR Caco2-BBE cell line was stably selected
in DMEM supplemented with 10% Tet system-FBS (Clontech)
and 10 mg/ml blasticidin (Invivogen).
Three CD98-siRNA candidates were purchased from Genscript
(siRNA1: J02939-680*-76 bp; siRNA2: J02939-972*-76 bp;
siRNA3: J02939-1130*-76 bp. *Positions in the hCD98 sequence,
accession no. NCBI NM_002394). Short hairpin (sh) constructs
were designed, generated and introduced into pRNATin-H1.2/
Hygro vector by GenScript. The TetR Caco2-BBE cell line was
transfected with the pRNATin-H1.2/Hygro empty vector or
CD98-shRNA constructs and stably selected in DMEM supple-
mented with 10% Tet system-FBS, 10 mg/ml blasticidin and
500 mg/ml hygromycin (Invivogen).
Recombinant protein production
The CD98-pRSET/His-B plasmid was constructed as previously
described [14]. CD98-pRSET/His-B S305A-S307A-S309A and
CD98-pRSET/His-B S426A-S430A mutants were generated using
specific primers P1 and P2 as described for the generation of hCD98-
pcDNA3.1/V5-His-TOPO S305A-S307A-S309A and hCD98-
pcDNA3.1/V5-His-TOPO S426A-S430A, respectively. These vec-
tors were transformed into E. coli strain BL21(DE3) pLys (Novagen,
Madison, WI), grown in LB media and induced with 0.1 M IPTG for
3 h. The cells were lysed with BugBuster Protein Extraction Reagent
(Novagen), sonicated and centrifuged. The insoluble pellet was
solubilized in 6 M urea for 1 h and centrifuged again. CD98 was
purified from the urea soluble fraction by elution off a HisBind Resin
column following the protocol of the HisBind Purification kit
(Novagen) with the following modifications: buffers were prepared
with the addition of 6 M urea. Column was washed with 4 vol of
binding buffer, 4 vol of 10 mM imidizole washing buffer and 4 vol of
15 mM imidizole washing buffer. CD98 was eluted with 3 vol of
120 mM imidizole elution buffer and 3 vol of 240 mM imidizole
elution buffer. 5 ml samples from each fraction were run on 10%
polyacrylamide gel and either stained with Coomassie Blue or
transferred to a nitrocellulose membrane for Western blot analysis.
Preparation of ePKs from Jurkat cells
Intact Jurkat cells were incubated with dephosphorylated a-
casein (Sigma, St Louis, MO) and the released ePKs were purified
as previously described [15]. Briefly, Jurkat cells adhered to a 96-
well plate (5610
5 cells/50 ml/well) were incubated with 250 mg/
ml dephosphorylated a-casein for 10 min at 37uC. The superna-
tants were pooled, and 10 mM diisopropylfluorophosphate was
added. The sample was centrifuged at 14,000 g for 10 min at 4uC.
The resulting supernatant was finally centrifuged at 100,000 g for
1 h at 4uC and stored at 270uC until use.
In vitro kinase assay
Recombinant CD98 (1 mg) was incubated with 50 ng CK2
(Upstate, Dundee, UK) in a buffer containing 30 mM Tris-HCl
pH 7.6, 1 mM EGTA, 150 mM NaCl, 50 mM KCl, 10 mM
MgCl2,4 0mM ATP, 2 mCi [c-
32P]ATP (30 Ci/mmol, Amer-
sham, Piscataway, NJ), 100 mMN a 3VO4, 100 mM NaF and
0.05% Triton X-100, in a total volume of 25 ml, at 30uC for
10 min. The reaction was terminated by addition of Laemmli
sample buffer, and samples were heated at 100uC for 5 min and
loaded on to 10% acrylamide gels. Gels were stained with
Coomassie Blue, destained and dried. Radiolabeled bands were
detected and quantified on a Typhoon 9200 PhosphorImager
(Amersham Pharmacia Biotech). Kinetics of the CK2-mediated
CD98 phosphorylation were determined by performing in vitro
kinase assays with different concentrations of recombinant CD98
and constant amounts of CK2 (50 ng) and [c-
32P]ATP (2 mCi).
Kinetic constants were determined from a Michaelis-Menten plot
using Enzyme Kinetic Program.
Phosphorylation of recombinant CD98 by ePKs from Jurkat
cells was performed by mixing 40 ml ePKs with 20 m1 NaCl-
HEPES for 10 min at 23uC. 20 ml NaCl-HEPES containing
10 mCi [c-
32P]ATP, 1 mg recombinant CD98, 400 mM MnC12,
800 mMN a 3VO4 and 800 mM NaF was added. The reaction was
performed at 37uC for 10 min. Samples were analyzed by SDS-
PAGE. Radiolabeled bands were detected by autoradiography.
Control reactions were performed under the same condition in the
absence of CD98, [c-
32P]ATP or CK2/ePKs, or in the presence of
myelin basic protein (Upstate, Lake Placid, NY). Inhibition kinase
assay was performed in the presence of 10 mM of the broad-
spectrum ePK inhibitor K252b (Calbiochem).
Ecto-protein kinase assay
Ecto-phosphorylation of CD98 expressed in Caco2-BBE cells
was performed using Jurkat cell-derived ePKs. 400 m1 ePKs was
CD98 Is Ecto-Phosphorylated
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23uC. 200 ml NaCl-HEPES containing 100 mCi [c-
32P]ATP,
400 mM MnC12, 800 mMN a 3VO4 and 800 mM NaF was added.
The reaction mixture was added into the basolateral compartment
of Caco2-BBE monolayers grown on filters for 10 min at 37uC.
Inhibition kinase assays were performed in the presence of 10 mM
of the ePK inhibitor K252b or 10 mM of the CK2-specific
inhibitor 4,5,6,7-Tetrabromobenzotriazole (TBB, Calbiochem).
Cells were washed with PBS and lysed in RIPA buffer as
previously described [16]. Cell lysates were immunoprecipitated
for CD98 or the irrelevant IgG1 using Catch and Release
Reversible Immunoprecipitation kit (Upstate Biotech).
Ecto-phosphorylation of CD98 in CHO cells by intact Jurkat
cells was performed as previously described [17] with some
modifications. Briefly, CHO cells in 12-well plates and suspended
Jurkat cells were washed with ecto-kinase buffer (HBSS, 10 mM
HEPES pH 7.4, 10 mM glucose, 10 mM MgCl2). The reaction
was initiated by adding 10
7 Jurkat cells in 400 ml of the ecto-kinase
buffer containing 20 mM ATP and 50 mCi [c-
32P]ATP to CHO
cells for 10 min at 37uC. Cells were lysed and immunoprecipitated
for CD98. The immunoprecipitates were analyzed by SDS-PAGE,
and radiolabeled bands were detected by autoradiography.
Membrane extraction and Western blot analysis
CHO cells were scraped in cold PBS and collected by
centrifugation at 2,000 g for 5 min. Cell pellets were suspended
and homogenized in 5 mM HEPES pH 7.4 for 30 min at 4uC,
and centrifuged at 13,000 g for 30 min at 4uC. The pellet was
resuspended in PBS and saved as membrane extract. Membrane
extracts were analyzed by SDS-PAGE and transferred to
nitrocellulose membranes. Western blot was performed as
previously described [16] using anti-V5 (Invitrogen), anti-CD98
(Santa Cruz), or anti-CD69 (Santa Cruz) antibody.
Binding assay of Jurkat cells on Caco2-BBE monolayers
Confluent Caco2-BBE cells cultured in 96-well plates were
incubated for 1 h at 37uC with 10 mg/ml of anti-CD98 antibody
or the irrelevant IgG1 (Sigma). Cells were washed, and Jurkat cells
in the ecto-kinase buffer containing 20 mM ATP were added to
Caco2-BBE monolayers (10
6 Jurkat cells/100 ml/well). Wells
incubated with PBS were used as background. After a 30-min
incubation at 37uC, the plate was washed with PBS and adherent
cells were quantified with a colorimetric reaction by adding 100 ml
hexosaminidase reagent (1% Triton X-100, 7.5 mM p-nitrophenyl
N-acetyl-b-D-glucosaminide, in 100 mM natrium-citrate buffer
pH 5.0) to each well for 40 min at 37uC. The reaction was stopped
with 1 N NaOH. Absorbance was measured at 405 nm. Results
were subtracted from background. Attached Jurkat cell numbers
were determined from a standard curve generated using known
Jurkat cell numbers.
Binding assay of Jurkat cells on CHO cells
Jurkat cells were labeled with 5 mM2 9,79-bis-(2-carboxyethyl)-
5(-6)carboxyfluorescein, acetoxymethyl ester (BCECF-AM, Mo-
lecular Probes) in culture media for 30 min at 37uC. After washes,
labeled Jurkat cells in the ecto-kinase buffer containing 20 mM
ATP were added (10
7 cells/400 ml/well) into CHO cells cultured
in 12-well plates. Wells incubated with PBS were used as
background. After a 30-min incubation at 37uC, wells were
washed, and attached cells were lysed with 10 mM Tris, 150 mM
NaCl, 3 mM EDTA and 1% Triton X-100. The fluorescence was
read using a fluorescence spectrophotometer (Hitachi F-4500,
Figure 1. Purification of recombinant CD98. SDS-PAGE analysis and Comassie Blue gel staining (A) and Western blot analysis using anti-CD98
antibody (B) of recombinant CD98 purification.
doi:10.1371/journal.pone.0003895.g001
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length, 520 nm). Results were subtracted from background.
Numbers of attached Jurkat cells were determined based on
calibration with lysates of BCECF-labeled Jurkat cells.
Attachment assay of Caco2-BBE or Jurkat cells on
recombinant proteins
Immulon 2HB 96-well high-binding plates (Thermo Scientific,
Waltham, MA) were incubated for 3 h at 37uC with 10 mg/ml of
recombinant CD98 or its mutated forms, or BSA used as a control.
Wells incubated with PBS were used as background. The plate was
washed with PBS and blocked with 3% BSA in PBS for 1 h at
37uC. Jurkat cells, pre-incubated with or without 10 mM K252b,
or Caco2-BBE cells, suspended in serum-free media, were then
added (2610
5 cells/100 ml/well) for 3 h at 37uC. Plates were
rinsed with PBS, and adherent cells were quantified using the
hexosaminidase-based colorimetric reaction as described above.
Results were subtracted from background. Attached cell numbers
were determined from standard curves generated using known
numbers of Caco2-BBE or Jurkat cells.
Cell adhesion measurement
Cell attachment and spreading were monitored using the
electric cell-substrate impedance sensing (ECIS) 1600R device
(Applied BioPhysics, Troy, NY). Caco2-BBE cells were seeded in
ECIS electrodes pre-coated with 10 mg/ml of different proteins.
Capacitance of cells was measured at 40 kHz, 1 V. The time
necessary for cells to spread out on half of the electrode (t1/2) and
the spreading rate of cells (s) were calculated for each electrode as
previously described [18].
Statistical analysis
Values are expressed as means6S.E.M. Statistical analysis was
performed using unpaired Student’s t-test. P,0.05 was considered
statistically significant.
Results
CD98 is phosphorylated in vitro by CK2 and ePKs
released from Jurkat cells
Analysis of the CD98 primary sequence using the NetPhos 2.0
server (http://www.cbs.dtu.dk/services/NetPhos/) indicated the
presence of potential phosphorylation sites in its extracellular C-
terminal tail. To determine whether CD98 is an in vitro substrate of
ePKs, we firstgenerated and purified recombinant CD98. The purity
of recombinant CD98 was verified by SDS-PAGE (Fig. 1A) and
Western blot (Fig. 1B). T cells have been found to possess ePKs
[17,19,20], and it has been reported that incubation of intact cells
with protein kinase substrates, such as casein, leads to the release of
ePKs [15]. Here, Jurkat cells were incubated with 0.25 mg/ml
Figure 2. Recombinant CD98 is phosphorylated in vitro by casein kinase 2 and ecto-protein kinases from Jurkat cells. In vitro
phosphorylation of 1 mg recombinant CD98 was performed using 2 mCi [c-
32P]ATP and 50 ng casein kinase 2 (CK2) (A) or 40 ml ecto-protein kinases
(ePKs) purified from Jurkat cells (B). Control reactions were performed under the same condition except the absence of recombinant CD98, or
[c-
32P]ATP, or CK2/ePKs, or the presence of 1 mg myelin basic protein (MBP). (C) Phosphorylation of recombinant CD98 by ePKs was performed in the
presence or absence of the ePK inhibitor K252b. The samples were analyzed by SDS-PAGE, and phosphorylated proteins were detected by
autoradiography. Bar graphs show the relative intensity of radiolabeled bands in the upper panel. Data are means6S.E.M of three determinations.
***P,0.001 vs white bar.
doi:10.1371/journal.pone.0003895.g002
CD98 Is Ecto-Phosphorylated
PLoS ONE | www.plosone.org 4 December 2008 | Volume 3 | Issue 12 | e3895dephosphorylated casein and ePKs released from the cells were
purified. Invitrokinaseassayswerethenperformedusingrecombinant
CD98, [c-
32P]ATP and Jurkat cell-derived ePKs or the commercial
CK2. Autoradiographic analysis revealed phosphorylated CD98
bands from both phosphorylation reactions with CK2 (Fig. 2A) and
with ePKs (Fig. 2B). As expected, there was no evidence of CD98
phosphorylation in control reactions performed in the absence of
[c-
32P]ATP or CK2/ePKs (Fig. 2A and B). Furthermore, 10 mMo f
the ePK inhibitor K252b [21,22,23] significantly inhibited CD98
phosphorylation (Fig. 2C) but did not influence the total amounts of
CD98 in the samples (data not shown). In addition, control reactions
lacking recombinant CD98 did not show any phosphorylated band
(Fig. 2A, B and C), indicating that the phosphorylation event was
specific for CD98. Collectively, these results demonstrate that CD98
is phosphorylated in vitro by ePKs, including CK2.
To determine the kinetic parameters of CK2-mediated CD98
phosphorylation, we performed in vitro kinase assays using
increasing concentrations of recombinant CD98 and constant
amounts of CK2 and [c-
32P]ATP. The samples were analyzed by
SDS-PAGE, and radiolabeled bands were detected by autoradi-
ography (Fig. 3, upper panel). The kinetic constant Km was
determined from a Michalis-Menten plot using the Enzyme
Kinetic Program. As summarized in Figure 3, kinetic analysis of
the in vitro phosphorylation of recombinant CD98 by CK2
revealed a Km=0.8460.20 (mM) for CD98. This Km is within
the range of protein phosphorylation by CK2 [11].
Serines-305/307/309 and serines-426/430 of CD98 are
the dominant phosphorylation sites for CK2
To further explore the ecto-domain of CD98, we generated
CD98 constructs mutated at the potential phosphorylation sites
serines-305/307/309 or serines-426/430 (Fig. 4A); these sites were
predicted with high score (S
305: 0.99; S
307: 0.97; S
309: 0.98; S
426:
0.99; S
430: 0.99) by the NetPhos 2.0 Server. Recombinant wild-
type CD98 or its mutated forms, CD98[S
305/307/309A] and
CD98[S
426/430A], were used as substrates for in vitro kinase assays
using CK2 and [c-
32P]ATP. Figure 4B shows that substitutions of
serines-305/307/309 or serines -426/430 by alanine residues
attenuated CD98 phosphorylation by ,78 and 79%, respectively.
The control reaction performed in the absence of recombinant
CD98 did not induce any phosphorylation (Fig. 4B, lane 2).
Together, these results suggest that serines-305/307/309 and
serines-426/430 are the dominant CD98 phosphorylation sites for
CK2.
CD98 expressed in Caco2-BBE cell membranes is ecto-
phosphorylated by Jurkat cell-derived ePKs
Having found that recombinant CD98 is phosphorylated by
ePKs in vitro, we then sought to determine whether CD98
expressed in the basolateral membranes of intestinal epithelial
Caco2-BBE cells is phosphorylated by ePKs. To accomplish this,
the basolateral surface of Caco2-BBE monolayers, grown on
filters, was exposed to a reaction mixture containing Jurkat cell-
derived ePKs and [c-
32P]ATP for 10 min at 37uC. For inhibition
study, the reactions were performed in the presence of the broad-
spectrum ePK inhibitor K252b or the CK2-specific inhibitor TBB.
The cells were lysed and immunoprecipitated for CD98 or the
irrelevant IgG1. Autoradiographic analysis of CD98 immunopre-
cipitate resolved by SDS-PAGE under reducing condition
revealed an 85-kDa phosphorylated band that represents glyco-
sylated CD98 (Fig. 5A, left panel). Under non-reducing conditions,
CD98 immunoprecipitate migrated as two radiolabeled bands of
,130 and ,250 kDa (Fig. 5A, right panel). The 130-kDa band
represents the heterodimer of CD98 and the amino-acid
transporter LAT-2 as we have previously shown [5], whereas
the 250-kDa band could be an association of CD98/LAT-2
heterodimer with other molecules. In the control IgG1 immuno-
precipitate, however, no radiolabeled band was detected under
either reducing or non-reducing condition (Fig. 5A). In addition,
10 mM of the cell-impermeable broad-spectrum ePK inhibitor
K252b markedly inhibited CD98 phosphorylation under both
reducing and non-reducing conditions, demonstrating that CD98
was ecto-phosphorylated by ePKs (Fig. 5A). To test if CK2 is
involved in the ecto-phosphorylation of CD98, phosphorylation
reaction was performed in the presence of 10 mM of TBB, a CK2-
specific inhibitor [24,25]. As shown in Figure 5A, TBB effectively
inhibited CD98 phosphorylation, indicating the involvement of
ecto-CK2 in this process. Collectively, these results suggest that
CD98 basolaterally expressed in Caco2-BBE monolayers is ecto-
phosphorylated by ePKs, including ecto-CK2, in its physiological
setting, where it may associate with other molecules to form multi-
component complexes.
CD98 plays a role in epithelial cell-T lymphocyte
interactions
Having shown that CD98 in Caco2-BBE cells is phosphorylated
by ePKs from Jurkat cells, we then asked if its phosphorylation
could be involved in interactions between IECs and T lympho-
Figure 3. Kinetics of recombinant CD98 phosphorylation by
casein kinase 2. Phosphorylation reactions were performed using
different concentrations of recombinant CD98 and constant amounts of
casein kinase 2 (CK2, 50 ng) and [c-
32P]ATP (2 mCi). Myelin basic protein
(MBP), used as a positive control, was phosphorylated under the same
condition. The samples were analysed by SDS-PAGE, and radiolabeled
bands were detected and quantified using a Storm Typhoon 9200
PhosphorImager. The kinetic constant Km was determined from a
Michalis-Menten plot using an Enzyme Kinetic Program. Data are
means6S.E.M of three determinations.
doi:10.1371/journal.pone.0003895.g003
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Jurkat cells on Caco2-BBE monolayers under the ecto-kinase
condition as described in Materials and Methods. Caco2-BBE
monolayers, cultured in 96-well plates, were pre-incubated with
CD98 antibody or the irrelevant IgG1, and Jurkat cells were
added. We found that incubation of Caco2-BBE cells with CD98
antibody significantly reduced Jurkat cell binding by ,31%
(Fig. 5B), suggesting a role for CD98 and/or its phosphorylation in
IEC-T lymphocyte interactions.
To further study the role of CD98 in cell-cell interactions, we
modulatedCD98proteinexpressioninCaco2-BBEcelllinesusinga
Tet-off system and studied the interactions between these cells and T
lymphocytes. Western blot analyses of TetR Caco2-BBE cells
transfected with three CD98-shRNA constructs after 2, 4 or 6 days
of treatment with 2.5 or 5 mg/ml tetracycline revealed that only the
CD98-shRNA3 construct (see Materials and Methods) was effective
in knocking down CD98, with highest repression effect after 2 days
of 2.5 mg/ml tetracycline treatment (Fig. 5C, left panel). Interest-
ingly, the CD98 silencing in Caco2-BBE cells consequently reduced
Jurkat cell binding by 39% (Fig. 5C, right panel). In contrast,
tetracycline treatment (2.5 mg/ml, 2 days) of TetR Caco2-BBE cells
transfected with the empty vector did not have any significant effect
on CD98 expression and Jurkat cell binding. Collectively, these
results point out the importance of epithelial CD98 and/or its
phosphorylation in IEC-T lymphocyte interactions.
Ecto-phosphorylation of CD98 expressed in CHO cells at
serines-305/307/309 and serines-426/430 is crucial for
Jurkat cell-CHO cell interactions
To confirm the functional involvement of CD98 phosphoryla-
tion in cell-cell interactions, we expressed variant CD98 constructs
(Fig. 4A) in CHO cells, which normally do not express CD98, and
examined the interactions between these cells and T lymphocytes.
CHO cells were transfected with the pcDNA3.1 TOPO/V5
vector (CHO/Vector), or the cDNA encoding wild-type CD98
(CHO/CD98) or phosphorylation-deficient CD98 mutants
(CHO/CD98[S
305/307/309A] and CHO/CD98[S
426/430A]) fused
with V5 protein. Western blot analyses using anti-CD98 or anti-
V5 antibody showed that exogenous wild-type and mutated CD98
proteins were successfully expressed in CHO cell membranes
(Fig. 6A). The role of CD98 phosphorylation in cell-cell
interactions was assessed by measuring adhesion of Jurkat cells,
in the ecto-kinase buffer containing non-radioactive ATP, on
confluent transfected CHO cells. Figure 6B shows that over-
Figure 4. Serines-305/307/309 and serines-426/430 of CD98 are the dominant phosphorylation sites for casein kinase 2. (A)
Schematic representation of the variant CD98 constructs. (B) In vitro phosphorylation of 1 mg of recombinant wild-type CD98 or its mutated forms
CD98[S
305/307/309A] and CD98[S
426/430A] was performed using 2 mCi [c-
32P]ATP and 50 ng casein kinase 2 (CK2) at 30uC for 10 min. A reaction
performed in parallel in the absence of recombinant CD98 (-CD98) was used as a negative control. The samples were analysed by SDS-PAGE.
Radiolabeled bands were detected by autoradiography. Bar graphs show the relative intensity of radiolabeled bands in the upper panel. Data are
means6S.E.M of three determinations. ***P,0.001 vs +CD98 (white bar).
doi:10.1371/journal.pone.0003895.g004
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(,2.2-fold) in Jurkat cell binding to CHO cells. Interestingly, the
numbers of Jurkat cells attached on CHO/CD98[S
305/307/309A]
and CHO/CD98[S
426/430A] were significantly decreased by
,1.9- and 1.7-fold, respectively, compared to that on CHO/
CD98 (Fig. 6B). To verify if CD98 expressed in CHO cells is ecto-
phosphorylated by Jurkat cells under this adhesion assay condition,
we performed an ecto-kinase assay by applying intact Jurkat cells
in the ecto-kinase buffer containing [c-
32P]ATP to CHO cells for
10 min at 37uC. Figure 6C shows a radiolabeled band in CD98
immunoprecipitate derived from CHO/CD98, demonstrating
that CD98 in these cells was ecto-phosphorylated. The incorpo-
ration of radioactive phosphate groups into CD98[S
305/307/309A]
and CD98[S
426/430A] expressed in CHO cell membranes was
remarkably suppressed by ,84 and 95%, respectively, compared
to that to wild-type CD98 (Fig. 6C). Collectively, these findings
confirm the ecto-phosphorylation of CD98 localized on the cell
surface and pointed out that such phosphorylation plays an
important role in heterotypic cell-cell interactions.
The C-terminal extracellular domain of CD98 is important
for cell-cell interactions
To further study the molecular mechanisms underlying CD98-
mediated cell-cell interactions, we generated chimeras of CD98 with
CD69: C98-T98-E69 contains cytoplasmic and transmembrane
domains of CD98 and the extracellular domain of CD69; C69-T69-
E98 contains cytoplasmicand transmembrane domains of CD69 and
the extracellular domainof CD98 (Fig. 7A). Wild-type CD98 and the
chimeras, subcloned into pcDNA3.1 TOPO/V5 vector, were stably
transfected into CHO cells. Western blot analyses of membrane
extracts from transfected CHO cells using anti-V5, anti-CD98 or
anti-CD69 antibody were performed to examine the expression of
Figure 5. CD98 in Caco2-BBE cells is phosphorylated by ecto-protein kinases from Jurkat cells and its role in epithelial cell-
lymphocyte interactions. (A) The basolateral surface of Caco2-BBE monolayers, grown on filters, was exposed to a reaction mixture containing
ecto-protein kinases purified from Jurkat cells and 50 mCi [c-
32P]ATP for 10 min at 37uC. Inhibition kinase assays were performed in the presence of
10 mM of the broad-spectrum ecto-protein kinase inhibitor K252b or 10 mM of the CK2-specific inhibitor 4,5,6,7-Tetrabromobenzotriazole (TBB). Cell
lysates were immunoprecipitated with anti-CD98 antibody or the irrelevant IgG1. The immunoprecipitates were analyzed by SDS-PAGE under
reducing or non-reducing conditions. Radiolabeled bands were detected by autoradiography. (B) Binding assays of Jurkat cells on Caco2-BBE
monolayers were performed under the ecto-kisase assay condition as described in Materials and Methods. Caco2-BBE cells cultured in 96-well plates
were pre-incubated for 1 h at 37uC with 10 mg/ml of CD98 antibody or the control IgG1, and Jurkat cells were added (10
6 Jurkat cells/100 ml/well) for
40 min at 37uC. Adherent cells were quantified by hexosaminidase-based colorimetric reaction. Data were subtracted from background, and the
numbers of attached Jurkat cells were determined from a standard curve generated using known numbers of Jurkat cells. (C) TetR Caco2-BBE cells
transfected with the CD98-shRNA3 construct or the empty vector were treated or not with 2.5 mg/ml tetracycline for 2 days and analysed for CD98
expression by Western blot (left panel), or were used for cell binding assay as described in (B) (right panel). Bar graphs show the relative intensity of
bands in the upper panel. Data are means6S.E.M of three determinations. *P,0.05; ***P,0.001; NS, not statically significant.
doi:10.1371/journal.pone.0003895.g005
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an epitope in the C-terminus of CD98, revealed the expression of
wild-type CD98 and C69-T69-E98 (Fig. 7B). However, this antibody
could not recognize C98-T98-E69, which lacks the C-terminus of
CD98 (Fig. 7B, lane 4). The expression of this protein was confirmed
by immunoblotting with anti-CD69 antibody (Fig. 7C, upper panel),
which recognizes an epitope in the C-terminus of CD69, or anti-V5
antibody (Fig. 7C, lower panel), which recognizes the fusion variants.
Adhesion assays of Jurkat cells on the transfected CHO cells were
then performed under the ecto-kinase assay condition. In agreement
with the data shown in Figure 6B, over-expression of CD98 in CHO
cells increased Jurkat cell binding by ,2.2 fold (Fig. 7D). Deletion of
the extracellular domain of CD98 (on CHO/C98-T98-E69)
abrogated this CD98-mediated increase in Jurkat cell binding,
reducing the numbers of attached Jurkat cells by ,72% relative to
that on CHO/CD98 (Fig. 7D). In contrast, Jurkat cell attachment on
CHO/C69-T69-E98, which lacks N-terminus of CD98, was not
significantly different from that on CHO/CD98 (Fig. 7D). These
data indicate that the C-terminal extracellular domain of CD98 is
important for cell-cell interactions.
Recombinant CD98 interacts with Caco2-BBE cells,
enhancing epithelial cell adhesion
Having established the importance of CD98 in cell-cell
interactions, we next turned our interest into the role of CD98 in
cell adhesion. Attachment and spreading of Caco2-BBE cells were
monitored quantitatively and in real time using the electric cell-
substrate impedance sensing (ECIS) technique. Capacitance of cells
at 40 kHz was measured on electrodes coated with 10 mg/ml of
recombinant CD98 or the control protein BSA. The time necessary
for cells to spread out on half of the available electrode (t1/2) and the
spreading rate of cells (s) were accordingly determined. Figure 8
shows that Caco2-BBE cells attached and spread significantly faster
on CD98 (black line: t1/2=560.46 h; s=0.560.06 nF/h) than on
BSA (grey line: t1/2=9.1261.65 h; s=0.3860.02 nF/h). Further-
more, microscopic images taken 8-h post-seeding show that Caco2-
BBE monolayers on CD98-coated electrodes were completely
confluent,whereasthoseonBSA-coatedelectrodeswere not(Fig.8),
supporting the capacitance measurement and spreading rate data.
Together, these results demonstrate that recombinant CD98
interacts with Caco2-BBE cell membranes and such interaction
enhances attachment and spreading of IECs.
Phosphorylation of recombinant CD98 increases its
interaction with Caco2-BBE cells and promotes epithelial
cell adhesion
The finding that CD98 interacts with Caco2-BBE cells led us to
hypothesize that its phosphorylation could affect the attachment and
spreading of IECs. To test this possibility, we compared Caco2-BBE
cell adhesion on phosphorylated CD98 with that on deficiently
Figure 6. Ecto-phosphorylation of CD98 in CHO cell membranes enhances Jurkat cell-CHO cell interactions. CHO cells were transfected
with the pcDNA3.1 TOPO/V5 vector (CHO/Vector) or V5-fused constructs of wild-type CD98 (CHO/CD98) or CD98 mutated at serines-305/307/309
(CHO/CD98[S
305/307/309A]) or sesrines-426/430 (CHO/CD98[S
426/430A]). (A) Western blot analysis of membrane extracts from transfected CHO cells
using anti-CD98 or anti-V5 antibody (upper panel). (B) Cell binding assays of fluorescent-labeled Jurkat cells on transfected CHO cells were performed
under the ecto-kinase assay condition as described in Materials and Methods. Data are means6S.E.M of three independent determinations.
**P,0.005 vs CHO/CD98; ***P,0.001. (C) Ecto-phosphorylation of CD98 expressed in CHO cells by intact Jurkat cells. Ecto-kinase assays were
performed by applying Jurkat cells in the ecto-kinase buffer containing 10 mCi [c-
32P]ATP to CHO cells for 10 min at 37uC. After washes, CHO cells
were lysed, immunoprecipitated for CD98 and analysed by SDS-PAGE. Radiolabeled bands were detected by autoradiography. Bar graphs show the
relative intensity of radiolabeled bands in the upper panel. Data are means6S.E.M of three determinations. ***P,0.001 vs CHO/CD98.
doi:10.1371/journal.pone.0003895.g006
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phosphorylation-deficient mutants CD98[S
305/307/309A] and
CD98[S
426/430A] were applied to in vitro kinase assays with ePKs in
the presence or absence of K252b, and cell adhesion on these
substrates was monitored using the ECIS device. Figure 9A shows
that K252b, which effectively inhibited CD98 phosphorylation in vitro
(Fig. 2C), reduced cell adhesion on phosphorylated CD98 (on
CD98+ePKs+K252b[grey line]: t1/2=7.2560.25 h, s=0.4860.04
nF/h vs on CD98+ePKs[black line]: t1/2=5.3560.3 h, s=
0.7260.02 nF/h). Furthermore, cell adhesion on phosph-
orylated CD98 was significantly faster than that on either
CD98[S
305/307/309A]+ePKs (orange line: t1/2=760.39 h; s=
0.4860.02 nF/h) or on CD98[S
426/430A]+ePKs (blue line: t1/2=
6.9560.1 h; s=0.560.02 nF/h) (Fig. 9A). Microscopic images
show that Caco2-BBE monolayers reached confluency at 8-h
post-seeding on (CD98+ePKs)-coated electrodes, but were not
confluent on electrodes coated with CD98+ePKs+K252b,
CD98[S
305/307/309A]+ePKs or CD98[S
426/430A]+ePKs (Fig. 9A).
These data strongly suggestthat the phosphorylation of CD98 at both
phosphorylation sites, serines-305/307/309 and serines-426/430,
contribute to the adhesive function of CD98.
Similar results were obtained from cell attachment assay
performed in 96-well high-binding plates. Plates were coated with
recombinant CD98, CD98[S
305/307/309A] or CD98[S
426/430A]
(non-phosphorylated; Fig. 9B), or with the proteins pre-applied to
in vitro kinase assays in the absence (+ePKs) or presence of K252b
(+ePKs+K252b) (Fig. 9B). Figure 9B shows a higher number of
Caco2-BBE cells attached on recombinant CD98 (2,2006260
cells/well) than on the control BSA (6365 cells/well), suggesting a
role of CD98 in cell attachment. Remarkably, ePK-mediated
phosphorylation of CD98 enhanced cell attachment by ,10-fold
(22,00563,500 cells/well on CD98+ePKs vs 2,2006260 cells/well
on non-phosphorylated CD98; Fig. 9B). As expected, cell
attachment on CD98[S
305/307/309A] or CD98[S
426/430A] was
not significantly increased when these phosphorylation-deficient
mutated proteins were pre-incubated with ePKs (Fig. 9B). The
numbers of cells binding on CD98[S
305/307/309A]+ePKs and
CD98[S
426/430A]+ePKs were decreased by ,81 and 72%,
respectively, compared to that on CD98+ePKs, although cell
attachment on non-phosphorylated CD98, CD98[S
305/307/309A]
and CD98[S
426/430A] was similar (Fig. 9B). Furthermore,
suppression of CD98 phosphorylation by K252b decreased cell
Figure 7. The extracellular C-terminal tail of CD98 expressed in CHO cell membranes is important for Jurkat cell-CHO cell
interactions. (A) Schematic representation of variant CD98 constructs used in this study: chimeras of CD98 with CD69 (C98-T98-E69 contains the
cytoplasmic and transmembrane domains of CD98 and the extracellular domain of CD69; C69-T69-E98 contains the cytoplasmic and transmembrane
domains of CD69 and the extracellular domain of CD98). (B) and (C) Western blot analysis using anti-CD98 (B), anti-CD69 (C) or anti-V5 (C) antibody of
membrane extracts from CHO cells stably transfected with the variant constructs. (D) Cell binding assays of fluorescent-labeled Jurkat cells on
transfected CHO cells under the ecto-kinase assay condition as described in Materials and Methods. Data are means6S.E.M of three determinations.
*P,0.05; (***P,0.001; NS, not statically significant) vs CHO/CD98.
doi:10.1371/journal.pone.0003895.g007
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CD98+ePKs+K252b vs 22,00563,500 cells/well on CD98+ePKs;
Fig. 9B). These observations strongly support the finding that
CD98 phosphorylation plays an important role in Caco2-BBE cell
adhesion.
Collectively, our results, obtained from Caco2-BBE cell
attachment measurements using the ECIS device and high-
binding plates, indicate that the phosphorylation of CD98,
dominantly at serines-305/307/309 and serines-426/430, enhanc-
es its interaction with IECs, promoting epithelial cell attachment
and spreading.
Phosphorylation of recombinant CD98 increases its
interaction with Jurkat cells and promotes cell
attachment
To investigate whether CD98 interacts with Jurkat cells and if
yes how phosphorylation of CD98 affects this interaction, we
performed cell attachment assays in 96-well plates coated with
recombinant wild-type CD98 or its mutated forms. Figure 10
shows that Jurkat cells attached better on wild-type CD98
(14,93161,670 cells/well) than on BSA (1,0206800 cells/well)
or on the phosphorylation-deficient mutants CD98[S
305/307/309A]
(4,18961,382 cells/well) and CD98[S
426/430A] (3,64061,010
cells/well). These data suggest that ePKs could be released from
Jurkat cells during the incubation of cells with CD98, leading to
CD98 phosphorylation and, consequently, an increase in Jurkat
cell attachment. Furthermore, K252b markedly decreased the
binding of Jurkat cells to CD98 by 83% (2,5056647 Jurkat
cells+K252b/well vs 14,9316577 Jurkat cells/well), but did not
significantly affect cell binding to CD98[S
305/307/309A] or
CD98[S
426/430A] (Fig. 10). Together, these data demonstrate that
CD98 interacts with Jurkat cells and this interaction is enhanced
by the phosphorylation of CD98.
Discussion
The present study shows that CD98 is phosphorylated and
demonstrates that the ecto-phosphorylation of CD98 is function-
ally important in cell-cell interactions. Our study has three major
findings. First, recombinant CD98 is phosphorylated in vitro by
CK2 and by ePKs from T lymphocytes. Second, CD98
basolaterally expressed in IECs can be ecto-phosphorylated at its
extracellular C-terminus, dominantly at serines-305/307/309 and
serines-426/430. Third, CD98 is involved in IEC adhesion, and
phosphorylation of CD98 enhances cell adhesion and cell-cell
interactions. Our findings suggest that the selective induction of
CD98 phosphorylation by ePKs is a pivotal event in IEC-T
lymphocyte interactions.
Figure 8. Recombinant CD98 interacts with Caco2-BBE cells and enhances epithelial cell attachment and spreading. Caco2-BBE cell
attachment was monitored in real-time using the electric cell-substrate impedance-sensing (ECIS) device. Caco2-BBE cells were seeded on electrodes
coated with 10 mg/ml of recombinant CD98 or BSA (2610
5 cells/electrode). Capacitance was measured at 40 kHz, 1 V. Microscopic images were taken
at t0 and 8-h post-seeding. Each image is a representative of quadruplicate electrodes. Bars, 50 mm. Half time (t1/2) and spreading rate (s) of the cells
were determined for each electrode. Data are means6S.E.M of three determinations. *P,0.05; **P,0.005.
doi:10.1371/journal.pone.0003895.g008
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through receptors for extracellular signals. The phosphorylation
and dephosphorylation of membrane proteins play an important
role in the regulation of many cellular functions [7]. For example,
T cell surface receptors, including cell adhesion proteins and
recognition molecules, are regulated through phosphorylation of
their extracellular domains [17,19,26,27]. CD98, originally
discovered as a surface antigen in lymphocytes [2], has been
found to be important in many biological processes, such as cell
adhesion, amino-acid transport and signal transduction [1]. The
presence of a C-terminal extracellular domain with potential
phosphorylation sites led us to propose that CD98 could be
extracellularly phosphorylated and such phosphorylation could
regulate its multiple functions.
Using kinase assays with extensively controlled conditions, we
showed that ePKs from Jurkat cells were as effective as the
commercial CK2 in phosphorylating recombinant CD98 in vitro.
CK2 is a ubiquitous and highly conserved serine/threonine kinase
[28] that has been reported to phosphorylate hundreds of putative
physiological substrates. The minimal consensus sequence for
CK2-mediated phosphorylation has been identified as S/T-X-X-
Acidic [29,30,31] where the +3 acidic residue can be Asp, Glu,
pSer [32,33] or pTyr [34], but apparently not pThr [32,34].
These observations, together with information given by NetPhos
2.0 Server, enabled us to identify serines-305/307/309 and
serines-426/430, located in the extracelullar domain of CD98,
as potential CK2 phosphorylation sites. We showed here that
alanine substitutions of serines-305/307/309 or serines-426/430
markedly reduced the incorporation of c-
32P into CD98 by CK2 in
vitro and attenuated the phosphorylation of CD98 in CHO cell
membranes by ePKs, indicating that these residues are the
dominant phosphorylation sites. The exact phosphorylation sites
in CD98 molecule remain within the scope of further investiga-
tions.
Figure 9. Phosphorylation of recombinant CD98 increases its interaction with Caco2-BBE cells and promotes epithelial cell
adhesion. (A) Recombinant wild-type CD98 or its mutated forms CD98[S
305/307/309A] and CD98[S
426/430A] (2 mg each) were applied to in vitro kinase
assays using 50 mM ATP and ecto-protein kinases (ePKs) purified from Jurkat cells in the presence or absence of 10 mM of the ePK inhibitor K252b.
Caco2-BBE cells were seeded on the electric cell-substrate impedance-sensing electrodes coated with these samples (2610
5 cells/electrode).
Capacitance was measured at 40 kHz, 1 V. Each microscopic image taken 8-h post-seeding is a representative of quadruplicate electrodes. Bars,
50 mm. Half time (t1/2) and spreading rate (s) of the cells were determined for each electrode. Data are means6S.E.M of three determinations.
(*P,0.05; **P,0.005) vs CD98+ePKs (black bar). (B) Cell attachment assays were performed in 96-well high-binding plates. Wells were coated with
10 mg/ml of BSA (control), recombinant wild-type CD98 or its mutated form CD98[S
305/307/309A] and CD98[S
426/430A]. Some wells were coated with
the proteins pre-applied to in vitro kinase assays with ePKs from Jurkat cells in the presence or absence of K252b. After incubation for 3 h at 37uC, the
plate was washed and blocked for 1 h at 37uC. Caco2-BBE cells were added (2610
5 cells/well) for 3 h at 37uC. After washes, attached cells were
quantified by a hexosaminidase-based calorimetric reaction. Data were subtracted from background, and the numbers of attached cells were
determined from a standard curve generated using known numbers of Caco2-BBE cells. Data are means6S.E.M of three determinations. (*P,0.05;
**P,0.005) vs CD98+ePKs; ***P,0.001; NS, not statically significant.
doi:10.1371/journal.pone.0003895.g009
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pressed in the intestinal epithelial Caco2-BBE cells is phosphor-
ylated by ePKs from Jurkat cells, and that ecto-CK2 is involved in
this process. Interestingly, CD98 is ecto-phosphorylated in its
physiological setting, where it associates with other molecules to
form multi-component complexes. We have previously reported
that CD98 forms heterodimers with amino-acid transporters, and
these heterodimers interact with b1-integrin [5] and the intercel-
lular adhesion molecule ICAM-1 [35] in the basolateral
membranes of IECs. The ecto-phosphorylation of CD98 investi-
gated here is of utmost importance since it represents a novel
mechanism by which CD98 may be involved in phosphorylation-
dependent transduction of extracellular signals into the cells.
The major finding of our study is that ecto-phosphorylation of
CD98 plays an important role in cell-cell interactions. Results
from cell attachment assays suggested that ecto-phosphorylation of
CD98 in Caco2-BBE cells was involved in Caco2-BBE cell-Jurkat
cell interactions. Furthermore, ecto-phosphorylation of CD98
expressed in CHO cells increased the binding of Jurkat cells to
CHO cells, and mutation at serines-305/307/309 or serines-426/
430 attenuated CD98 phosphorylation by Jurkat cells and
consequently reduced cell-cell interactions. Importantly, we
demonstrated that the C-terminal extracellular domain of CD98,
which possesses phosphorylation sites, was crucial for the
heterotypic cell-cell interactions. Together, these findings suggest
that the phosphorylation of CD98 on its extracellular domain by
ePKs from T lymphocytes is important for epithelial cell-T
lymphocyte interactions. In addition, applying the ECIS technol-
ogy to monitor IEC adhesion on different substrates in real time,
we demonstrated that attachment and spreading of Caco2-BBE
cells on recombinant CD98 were enhanced when CD98 was
phosphorylated. In agreement with the ECIS data, cell adhesion
assays performed in 96-well high-binding plates showed that the
attachment of Caco2-BBE and Jurkat cells was increased on
phosphorylated recombinant CD98. Mutation at both phosphor-
ylation sites, serines-305/307/309 and serines-426/430, abolished
the effect of ePK-mediated CD98 phosphorylation on cell
adhesion, further demonstrating the contribution of phosphoryla-
tion to the adhesive function of this molecule. These results
strongly suggest that the phosphorylation of CD98 could modulate
its specific ability to interact with membranes of other cells, which
might account for homotypic and/or heterotypic cell-cell
interactions.
Previous sdudies have demonstrated that several proteins that are
involved in cell adhesion can be extracellularly phosphorylated and
that their ecto-phosphorylation can regulate cell adhesion and cell
migration. It has been reported that vitronectin, an extracellular
maxtrix glycoprotein, is phosphorylated by CK2 on the surface of
blood cells, and that cell adhesion on CK2-phosphorylated
vitronectin is enhanced via the alpha(v)beta3 integrin [36]. Ecto-
CK2-mediated vitronectin phosphorylation was also shown to be
important to vascular smooth muscle cell adhesion [37]. Similarly,
laminin-1 can be phosphorylated by CK2-type ePKs of monocyte,
and its phosphorylation increases cell adhesion, cell proliferation as
well as cell migration [21]. Recently, the cell surface receptor
collagen XVII was identified as a substrate of ecto-CK2 [38]. Ecto-
phosphorylation of collagen XVII was also demonstrated to inhibit
its ecto-domain shedding, which is involved in the regulation of
adhesion, motility and differentiation of epithelial cells [38].
Together with these investigations, our finding that ecto-phosphor-
ylation of CD98 promotes cell adhesion suggest that the
extracellular phosphorylation of cell-surface proteins and extracel-
lular matrix proteins seems to be the general mechanism underlying
the regulation of cell adhesion.
The involvement of CD98 ecto-phosphorylation in cell-cell
interactions found here is of great importance from a
pathophysiological perspective because the interactions between
IECs and lymphocytes play a key role in immune responses
within the intestinal tract [39]. It is interesting to speculate that
under pathological conditions, where extracellular ATP required
for ecto-phosphorylation can reach high concentration [7],
CD98 phosphorylation is especially effective, which affects cell-
cell interactions and consequently regulates T cell-mediated
immune responses. Further studies are required to investigate
which physiological and/or pathological state(s) can actuate this
mechanism. Previous studies have suggested a role for CD98 in
the etiology of inflammatory disorders. Pro-inflammatory
cytokines have been shown to upregulate CD98 expression in
IECs [14,40]. Increased levels of lymphocyte-activation antigens,
including CD98, have been found at the cell surface of
intestinal B cells, CD4
+ T cells and CD8
+ T cells isolated
from patients with inflammatory bowel disease [41]. We have
Figure 10. Phosphorylation of recombinant CD98 increases its interaction with Jurkat cells and enhances cell attachment.
Attachment of Jurkat cells was assayed in 96-well high-binding plates coated with 10 mg/ml of BSA (control), recombinant wild-type CD98 or its
mutated forms CD98[S
305/307/309A] and CD98[S
426/430A] for 3 h at 37uC. The plate was washed and blocked for 1 h at 37uC. 2610
5 Jurkat cells, pre-
incubated without (Jurkat+vehicle) or with 10 mM of the ecto-protein kinase inhibitor K252b for 30 min at 37uC (Jurkat+K252b), were added to each
well for 3 h at 37uC. After washes, attached cells were quantified using a hexosaminidase-based calorimetric method. Results were subtracted from
background. The numbers of attached cells were determined from a standard curve generated using known numbers of Jurkat cells. Data are
means6S.E.M of three determinations. ***P,0.001 vs (Jurkat+vehicle) on CD98;
#P,0.001;
*P ,0.05.
doi:10.1371/journal.pone.0003895.g010
CD98 Is Ecto-Phosphorylated
PLoS ONE | www.plosone.org 12 December 2008 | Volume 3 | Issue 12 | e3895recently showed that CD98 expression is highly upregulated in
colonic tissues from mice with active colitis, and that activation
of epithelial CD98 aggravates intestinal inflammation [42].
These studies and our present findings suggest that CD98 could
be a potential pharmacological target to manipulate lymphocyte
activation and IEC-lymphocyte interactions during intestinal
inflammation.
The molecular mechanism by which the ecto-phosphorylation
of CD98 modulates cell-cell interactions remains to be elucidated.
It is tempting to speculate that CD98 ecto-phosphorylation could
have substantial effects on the binding affinity of CD98 for
proteins expressed on the surface of other cells. However, we
cannot exclude the possibility that the phosphorylation of CD98
may functionally affect other proteins that interact with CD98 and
are involved in cell-cell interactions.
In conclusion, our study demonstrates that CD98 is ecto-
phosphorylated by ePKs, including ecto-CK2, dominantly at
serine-305/307/309 and serine-426/430, and that the ecto-
phosphorylation of CD98 plays an important role in cell-cell
interactions. Our findings reveal a novel mechanism underlying
the regulation of the multiple functions of CD98 and suggest that
CD98 could be a promising target for therapeutic strategies to
prevent aberrant cell-cell interactions, which have been implicated
in the pathogenesis of various intestinal diseases.
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